REFERENCES
- Antman K, Amato D, Wood W, Corson J, Suit H, Proppe K, Carey R, Greenberger J, Wilson R, Frei E, 3rd. Selection bias in clinical trials. J Clin Oncol Aug, 1985; 3(8)1142–1147
- Bahit M C, Cannon C P, Antman E M, Murphy S A, Gibson C M, McCabe C H, Braunwald E. Direct comparison of characteristics, treatment, and outcomes of patients enrolled versus patients not enrolled in a clinical trial at centers participating in the TIMI 9 Trial and TIMI 9 Registry. Am Heart J Jan, 2003; 145(1)109–117
- Smith P, Arnesen H. Mortality in non-consenters in a post-myocardial infarction trial. J Intern Med Sep, 1990; 228(3)253–256
- Britton A, McKee M, Black N, McPherson K, Sanderson C, Bain C. Threats to applicability of randomised trials: Exclusions and selective participation. J Health Serv Res Policy Apr, 1999; 4(2)112–121
- Feuer E J, Frey C M, Brawley O W, Nayfield S G, Cunningham J B, Geller N L, Bosl G J, Kramer B S. After a treatment breakthrough: A comparison of trial and population-based data for advanced testicular cancer. J Clin Oncol Feb, 1994; 12(2)368–377
- Vist G E, Hagen K B, Devereaux P J, Bryant D, Kristoffersen D T, Oxman A D. Outcomes of patients who participate in randomised controlled trials compared to similar patients receiving similar interventions who do not participate. Cochrane Database of Methodology Reviews 2004, Issue 4. Art. No.: MR000009
- Collaborative Ocular Melanoma Study Group. Design and methods of a clinical trial for a rare condition: The Collaborative Ocular Melanoma Study. Controlled Clin Trials Oct, 1993; 14(5)362–391, COMS Report No. 3
- Collaborative Ocular Melanoma Study Group. Sociodemographic and clinical predictors of participation in two randomized trials: Findings from the Collaborative Ocular Melanoma Study. Control Clin Trials Oct, 2001; 22(5)526–537, COMS Report No. 7
- Collaborative Ocular Melanoma Study Group. The Collaborative Ocular Melanoma Study (COMS) randomized trial of pre-enucleation radiation of large choroidal melanoma I: Characteristics of patients enrolled and not enrolled. Am J Ophthalmol Jun, 1998; 125(6)767–778, COMS Report No. 9
- Collaborative Ocular Melanoma Study Group. The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma. II. Characteristics of patients enrolled and not enrolled. Arch Ophthalmol Jul, 2001; 119(7)951–965, COMS Report No. 17
- Chang A E, Karnell L H, Menck H R. The National Cancer Data Base report on cutaneous and noncutaneous melanoma: A summary of 84,836 cases from the past decade. The American College of Surgeons Commission on Cancer and the American Cancer Society. Cancer Oct 15, 1998; 83(8)1664–1678
- Patel J K, Didolkar M S, Pickren J W, Moore R H. Metastatic pattern of malignant melanoma. A study of 216 autopsy cases. Am J Surg Jun, 1978; 135(6)807–810
- Collaborative Ocular Melanoma Study Group. Assessment of metastatic disease status at death in 435 patients with large choroidal melanoma in the Collaborative Ocular Melanoma Study (COMS): COMS Report No. 15. Arch Ophthalmol May, 2001; 119(5)670–676
- Collaborative Ocular Melanoma Study Group. The Collaborative Ocular Melanoma Study (COMS) randomized trial of pre-enucleation radiation of large choroidal melanoma II: Initial mortality findings. COMS Report No. 10. Am J Ophthalmol Jun, 1998; 125(6)779–796
- Collaborative Ocular Melanoma Study Group. The Collaborative Ocular Melanoma Study (COMS) randomized trial of pre-enucleation radiation of large choroidal melanoma: IV. Ten-year mortality findings and prognostic factors. COMS Report Number 24. Am J Ophthalmol Dec, 2004; 138(6)936–951
- Collaborative Ocular Melanoma Study Group. The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma, III: Initial mortality findings. COMS Report No. 18. Arch Ophthalmol Jul, 2001; 119(7)969–982
- Collaborative Ocular Melanoma Study Group. The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma: V. Twelve-year mortality rates and prognostic factors: COMS Report No. 28. Arch Ophthalmol Dec, 2006; 124(12)1684–1693
- Landis J R, Koch G G. The measurement of observer agreement for categorical data. Biometrics Mar, 1977; 33(1)159–174
- Collett D. Modelling Survival Data in Medical Research. Chapman and Hall, London 1994; 192–195
- McWilliams R, Hoover-Fong J, Hamosh A, Beck S, Beaty T, Cutting G. Problematic variation in local institutional review of a multicenter genetic epidemiology study. JAMA Jul, 2003; 16: 360–366, 290(3)
- Davis K B, Fisher L, Gillespie M J, Pettinger M. A test of the National Death Index using the Coronary Artery Surgery Study (CASS). Control Clin Trials Sep, 1985; 6(3)179–191
- Sesso H D, Gaziano J M, Van Denburgh M, Hennekens C H, Glynn R J, Buring J E. Comparison of baseline characteristics and mortality experience of participants and nonparticipants in a randomized clinical trial: The Physicians' Health Study. Control Clin Trials Dec, 2002; 23(6)686–702
- Semmens J B, Lawrence-Brown M M, Fletcher D R, Rouse I L, Holman C D. The Quality of Surgical Care Project: a model to evaluate surgical outcomes in Western Australia using population-based record linkage. Aust N Z J Surg Jun, 1998; 68(6)397–403
- Olsen J, Melbye M, Olsen S F, Sorensen T I, Aaby P, Andersen A M, Taxbol D, Hansen K D, Juhl M, Schow T B, Sorensen H T, Andresen J, Mortensen E L, Olesen A W, Sondergaard C. The Danish National Birth Cohort-its background, structure and aim. Scand J Public Health Dec, 2001; 29(4)300–307
- Sennerby U, Farahmand B, Ahlbom A, Ljunghall S, Michaelsson K. Cardiovascular diseases and future risk of hip fracture in women. Osteoporos Int May, 2007; 10
- Tang S T, Chen M L, Huang E W, Koong S L, Lin G L, Hsiao S C. Hospice utilization in Taiwan by cancer patients who died between 2000 and 2004. J Pain Symptom Manage Apr, 2007; 33(4)446–453